Evvy raises $40 million for women's health research

The company Evvy, which focuses on women's health, has announced that it has completed a $40 million Series B funding round. The investment is led by Catalio Capital Management and is intended to support further research on the vaginal microbiota, a crucial aspect affecting female health.

Evvy's focus on unlocking data related to the vaginal microbiota is innovative and can lead to significantly greater insight into the health issues that many women experience. The data the company collects and analyzes can contribute to a better understanding of how these microbiota vary and what impact they have on health outcomes such as infections and reproductive conditions.

The new funding will also be used to expand Evvy's product offerings and improve access to critical health information for women. By combining technology with medical knowledge, Evvy aims to empower women in their health choices and provide them with accurate and relevant information.

The circulation of such transparent and scientifically backed data can ultimately influence more targeted and personalized healthcare treatments for women.

Read the full article from Techcrunch.